期刊文献+

根除幽门螺杆菌临床疗效观察 被引量:3

Clinical observation on the therapeutic effect of eradication of Helicobacter pylori
暂未订购
导出
摘要 目的:观察四疗联疗法与三联疗法根除幽门螺杆菌(H.pylori,HP)的疗效。方法:将116例14C呼气试验或胃黏膜快速尿素酶试验阳性的慢性胃炎或胃溃疡患者随机分为两组,A组56例,B组60例。A组采用三联疗法,给予兰索拉唑30 mg,1次/d,阿莫西林1.0、克拉霉素0.5,2次/d。B组在A组的基础上加用果胶铋胶囊,给予果胶铋胶囊150 mg,4次/d。疗程均为7d。在疗程结束后,停药4周后复查HP。结果:按PP分析两组HP根除率,差异无统计学意义(P>0.05)。但在效果分析上,四联疗法治疗方案根除率高于三联疗法。结论:四联疗法对于幽门螺杆菌根除具有较高的疗效。 Objective To observe the clinical efficacy of the quadruple therapy versus triple therapy for eradication of Helicobacter pylori(H.pylori,HP).Method 116 cases with 14C breath test or gastric mucosa rapid urease test and positive chronic gastritis or gastric ulcer patients were randomly divided into A group with 56 cases and group B with 60 cases.Group A had triple lansoprazole therapy to 30mg,1g/1Day,Amoxicillin,Clarithromycin 0.5 2 times/Day,B group based on A group but with the use of bismuth pectin capsules,for bismuth pectin capsules 150mg,4times/Day;Both groups were treated for 7day.The two groups were in the course of treatment after 4 weeks after HP.Results By PP analysis,2 groups had no significant difference between H.pylori eradication.But in effect analysis,quadruple therapy regimen′s eradicating rate was higher than the triple therapy.Conclusion Quadruple therapy for eradication of Helicobacter pylori(HP) has a high efficacy.
出处 《吉林医学》 CAS 2013年第13期2418-2419,共2页 Jilin Medical Journal
关键词 幽门螺杆菌 根除 兰索拉唑 果胶铋 Helicobacter pylori Eradication Lansoprazole Bismuth pectin
  • 相关文献

参考文献4

二级参考文献21

  • 1FORD A, MOAYYEDI P. How can the current strategies for Helicobacter pylori eradication therapy be improved? [J]. Can J Gastroenterol, 2003, 17 (Suppl B) : 36B- 40B.
  • 2ZULLO A, GATTA L, DE FRANCESCO V, et al. High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with pepticulcer: a prospective controlled study [J]. Aliment Pharmacol Ther, 2005, 21 (12): 1419-1424.
  • 3SCACCIANOCE G, HASSAN C, PANARESE A, et al. Helicobaeter pylori eradication with either 7-day or 10-day triple therapies, and with a 10-day sequential regimen [J]. Can J Gastroenterol, 2006, 20 (2) : 113-117.
  • 4VAIRA D, ZULLO A, VAKILN, et al. Sequential therapy versus standard triple drug therapy for Helicobacter pylori eradication: a randomized trial [ J ]. Ann Intern Med, 2007, 146 (8): 556-563.
  • 5RAJINIKANTH P S, MISHRA B. Stomach-site specific drug delivery system of clarithromycin for eradication of Helicobacter pylori [ J ] . Chem Pharm Bull ( Tokyo ), 2009, 57 (10): 1068-1075.
  • 6DE FRANCESCO V, MARGIOTTA M, ZULLO A, et al. Clarithromycin-resistant genotypes and eradication of Helicobacter pylori [ J]. Ann Intern Med, 2006, 144 (2) : 94-100.
  • 7成虹,胡伏莲,谢勇,胡品津,王吉耀,吕农华,张建中,张桂英,周曾芬,吴克利,张玲霞,彭孝伟,戴宁,唐国都,姜葵,李岩,侯晓华,白文元,王明春,叶红军,刘玉兰,许乐.中国幽门螺杆菌耐药状况以及耐药对治疗的影响—全国多中心临床研究[J].胃肠病学,2007,12(9):525-530. 被引量:519
  • 8Fischbach L, Evana EL. Meta-analysis;the effect of antibiotic resist- ance status on the efficacy of triple and quadruple first-line theraies for Helicobacter pylori [ J 1. Aliment Pharmacol Ther, 2007,26 ( 3 ) : 343 - 357.
  • 9] Megraud F. H. pylori antibiotic resistance : p revalence, importance, and advances in testing [ J ]. Gut, 2004,53 ( 9 ) : 1374 - 1384.
  • 10Datta S, Chattopadhyay S, Patra R, et al. Most Helicobacter pylori strains of Kalkota in India are resistant to metronidazole but suscep- tible to other drugs commonly used for eradication and ulcer therapy [ J]. Aliment Phamacol Ther,2005,22( 1 ) :51 -57.

共引文献57

同被引文献31

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部